Advertisement

Topics

Battelle Ventures, L.P. Company Profile

13:53 EST 15th December 2018 | BioPortfolio

Battelle Ventures, L.P., and its affiliate fund, Innovation Valley Partners (IVP), have a combined $255 million under management for creating and accelerating the development of early-stage technology companies with breakthrough solutions to key marketplace problems. The funds have enjoyed close relationships with the technology transfer offices of the National Laboratories that Battelle Ventures’ sole limited partner, Battelle Memorial Institute (Battelle), manages or co-manages for the U.S. Department of Energy. They also have similar associations with a number of university technology transfer and commercialization departments. For more information, please visit www.battelleventures.com and www.battelleventures.com/tracy.html


News Articles [346 Associated News Articles listed on BioPortfolio]

Startup Future Family rakes in $10M to expand subscription fertility service

Aspect Ventures led the $10 million Series A round. BBG Ventures, LaunchCapital, iNovia, RiverPark Ventures, Ulu Ventures, Day One Ventures and Portfolia participated.

Battelle to Help in Fight Against Lead Poisoning

Programs with Centers for Disease Control and Prevention (CDC) target increased safety in housing and children Battelle recently won a one-year award for nearly $1 mill...

League raises fresh capital to grow employee health benefits platform

The Canadian startup secured C$62 million (or about $47.5 million) in a round led by TELUS Ventures. Wittington Ventures, OMERS, RBC Ventures, Real Ventures, Infinite Potential Group and BDC IT Ventu...

Dr. John Lechleiter Elected to Battelle Board of Directors

Former Eli Lilly and Company CEO brings strong science-driven, business-oriented expertise to innovation Battelle announced today that Dr. John Lechleiter, retired President, ...

VelosBio closes $58mm Series A round

Oncology start-up VelosBio Inc. raised $58mm through its Series A round. Arix Bioscience and Sofinnova Ventures co-led and were joined by Pappas Ventures, Chiesi Ventures, and returning backers Takeda...

Neurotherapeutics discovery start-up System1 closes $25mm Series A round

System1 Biosciences Inc. (neurological and psychiatric disorder drug discovery using phenotypic screening) completed a $25mm Series A round co-led by CRV and Pfizer Ventures (both add board members). ...

StrideBio gets $15.7mm via Series A

StrideBio Inc. (developing novel adeno-associated viral (AAV) vectors for in vivo gene therapies aimed at rare diseases) raised $15.7mm in an oversubscribed Series A financing led by Hatteras Venture ...

Series B round brings $12.6mm to Gauss Surgical

Gauss Surgical Inc. (markets the Triton system for real-time blood loss monitoring during surgery and childbirth) raised $12.6mm in its Series B round from Providence Ventures (lead), Jump Capital, Pr...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Avant ex [B4 Ventures LLC]

B4 Brands: Avant EX Instant Hand Sanitizer

Avant foaming hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free

Avant original instant hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Original Instant Hand Sanitizer

Aterra antibacterial hand wash [B4 Ventures LLC]

B4 Brands: Aterra Antibacterial Hand Soap

Avant original - fragrance free [B4 Ventures LLC]

B4 Brands: Avant Original - Fragrance Free Instant Hand Sanitizer

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Estimating and valuing the carbon release in scenarios of land-use and climate changes in a Brazilian coastal area.

Deforestation is a significant source of man-made carbon in the atmosphere, contributing to the greenhouse gas (GHG) effect. Although carbon releases are associated to the ecosystem functions of clima...

"Yes, we know!" (Over)confidence in general knowledge among Austrian entrepreneurs.

Overconfidence has been reported to be a common bias among entrepreneurs and might be one cause of the high failure rates observed for new ventures. In this study, we investigate the overconfidence bi...

CAREGIVER SENSITIVITY AND CONSISTENCY AND CHILDREN'S PRIOR FAMILY EXPERIENCE AS CONTEXTS FOR EARLY DEVELOPMENT WITHIN INSTITUTIONS.

The current study addressed whether two institution-wide interventions in St. Petersburg, Russian Federation, that increased caregiver sensitivity (Training Only: TO) or both caregiver sensitivity and...

The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.

It is evidenced that 20% of all tumors in humans are caused by oncoviruses including Human Papilloma Viruses (HPV), Epstein-Barr Virus (EBV), Kaposi Sarcoma Virus (KSHV), Human Polyomaviruses (HPyV), ...

Detecting opinion spams through supervised boosting approach.

Product reviews are the individual's opinions, judgement or belief about a certain product or service provided by certain companies. Such reviews serve as guides for these companies to plan and monito...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Evaluation of a Digital Microscope for Malaria

Light microscopy, which is based on century-old technology, remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalaria...

Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)

Microscopy remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalarials or in the context of regulatory clinical trial...

Companies [571 Associated Companies listed on BioPortfolio]

Battelle Ventures, L.P.

Battelle Ventures, L.P., and its affiliate fund, Innovation Valley Partners (IVP), have a combined $255 million under management for creating and accelerating the development of e...

Battelle Ventures

Battelle Ventures, L.P., and its affiliate fund, Innovation Valley Partners (IVP), have a combined $255 million under management for creating and accelerating the development of e...

UT-Battelle

A not-for-profit company, known as UT-Battelle, has been established for the sole purpose of managing and operating the Oak Ridge National Laboratory for the U.S. Department of Energy. Formed as a 50-...

Battelle and Canopy Growth Corporation

Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle condu...

Battelle is a global science and technology enterprise

Battelle is a global science and technology enterprise that develops and commercializes technology and manages laboratories for customers. Headquartered in Columbus, Ohio, Battelle has a vast science ...

More Information about "Battelle Ventures, L.P." on BioPortfolio

We have published hundreds of Battelle Ventures, L.P. news stories on BioPortfolio along with dozens of Battelle Ventures, L.P. Clinical Trials and PubMed Articles about Battelle Ventures, L.P. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Battelle Ventures, L.P. Companies in our database. You can also find out about relevant Battelle Ventures, L.P. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record